Some cell subpopulations showed acceptable variations in different tumor or NAT samples, such as the C1, C3, and C5 T cells in NAT samples, while some showed large variations in different tumor or NAT samples, such as the C1, C2, and C3 epithelial cells in tumor samples. This evidence concerns the gene BRD2 and neoplasm.